US 11679079
Ophthalmic formulations and related methods
granted A61KA61K47/24A61K47/26
Quick answer
US patent 11679079 (Ophthalmic formulations and related methods) held by ETERNATEAR, INC. expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ETERNATEAR, INC.
- Grant date
- Tue Jun 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K47/24, A61K47/26, A61K47/44, A61K9/0048